Zimmer Biomet wins FDA nod for Sidus stem-free shoulder system (MassDevice)
Zimmer Biomet (NYSE:ZBH) said today it won FDA clearance for its Sidus stem-free shoulder system.
The newly cleared Sidus system is designed as a total shoulder arthroplasty solution for patients with good bone stock with either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head or those who’ve had previous surgeries of the shoulder that don’t compromise fixation, the Warsaw, Ind.-based company said.
“The Sidus stem-free shoulder system offers a novel approach to total shoulder arthr...
